Investigation Report on China Sodium Hyaluronate Market, 2010-2019
Description
Sodium hyaluronate is a long-chain polymer containing repeating disaccharide units of Na-glucuronate-N-acetylglucosamine. As a major ingredient of synovial fluid and cartilage matrix, sodium hyaluronate can lubricate the joint, protect cartilage of the joint, improve joint contracture and pathological articular fluid. Sodium hyaluronate eye drop is used for the treatment of dry eyes and mechanical lesion to corneal endothelium while sodium hyaluronate injection is used as a joint function-improving agent for intra-articular injection on osteoarthropathy patients.
Currently, only sodium hyaluronate injection and eye drop are available in the market. The raw materials of sodium hyaluronate can be classified into pharmaceutical grade, external grade and edible grade.
Currently, hyaluronate is mainly used as the raw material of artificial synovial fluid and eye drops after eye surgery which together brought in a global sales value of USD 700-800 million. This figure is estimated to reach up to USD 3 billion if its cosmetics are counted too.
In the middle of 1990s, preparations of sodium hyaluronate began to be used in the clinic in China, achieving good efficacy in ophthalmology, orthopaedics and surgery. Sodium hyaluronate develops fast after entering China, annual sales value rising from less than CNY 100 million in 2005 to CNY 290 million in 2014 and CAGR during this period reaching 18.61%. Sodium hyaluronate enjoys a vast demand in China. Seikagaku Corporation (Japan), United Laboratories, Bausch & Lomb, Santen Pharmaceutical Co., Ltd (Japan), Shanghai Jingfeng Pharmaceutical Co., Ltd and URSAPHARM Arzneimittel GmbH Co.KG (GE) all take up certain shares in the market, among which Seikagaku Corporation (Japan) has the largest market share of 29% for sales value in 2014.
Over the last decade, the demand for sodium hyaluronate in the area of health has kept increasing. With the ever-growing demand of life quality and the rapid ageing of urban population (senile diseases like cataract and osteoarthritis, the market size of sodium hyaluronate will continue to expand in China.
Readers can get at least the following information from this report:
Sodium hyaluronate is a long-chain polymer containing repeating disaccharide units of Na-glucuronate-N-acetylglucosamine. As a major ingredient of synovial fluid and cartilage matrix, sodium hyaluronate can lubricate the joint, protect cartilage of the joint, improve joint contracture and pathological articular fluid. Sodium hyaluronate eye drop is used for the treatment of dry eyes and mechanical lesion to corneal endothelium while sodium hyaluronate injection is used as a joint function-improving agent for intra-articular injection on osteoarthropathy patients.
Currently, only sodium hyaluronate injection and eye drop are available in the market. The raw materials of sodium hyaluronate can be classified into pharmaceutical grade, external grade and edible grade.
Currently, hyaluronate is mainly used as the raw material of artificial synovial fluid and eye drops after eye surgery which together brought in a global sales value of USD 700-800 million. This figure is estimated to reach up to USD 3 billion if its cosmetics are counted too.
In the middle of 1990s, preparations of sodium hyaluronate began to be used in the clinic in China, achieving good efficacy in ophthalmology, orthopaedics and surgery. Sodium hyaluronate develops fast after entering China, annual sales value rising from less than CNY 100 million in 2005 to CNY 290 million in 2014 and CAGR during this period reaching 18.61%. Sodium hyaluronate enjoys a vast demand in China. Seikagaku Corporation (Japan), United Laboratories, Bausch & Lomb, Santen Pharmaceutical Co., Ltd (Japan), Shanghai Jingfeng Pharmaceutical Co., Ltd and URSAPHARM Arzneimittel GmbH Co.KG (GE) all take up certain shares in the market, among which Seikagaku Corporation (Japan) has the largest market share of 29% for sales value in 2014.
Over the last decade, the demand for sodium hyaluronate in the area of health has kept increasing. With the ever-growing demand of life quality and the rapid ageing of urban population (senile diseases like cataract and osteoarthritis, the market size of sodium hyaluronate will continue to expand in China.
Readers can get at least the following information from this report:
- market size of sodium hyaluronate in China
- competitive landscape of sodium hyaluronate in Chinese market
- price of sodium hyaluronate made by different enterprises in China
- market outlook of sodium hyaluronate in China
- pharmaceutical enterprises
- investors/ research institutions interested in Chinese medicine market
- any interest in the Chinese medicine market, please contact CRI for customized survey service
1 RELATED CONCEPTS OF SODIUM HYALURONATE
1.1 Indication
1.2 Sales Status in Global Market
2 MARKET PROFILE OF SODIUM HYALURONATE IN CHINA
2.1 Patent and Approval Status of Sodium Hyaluronate in China
2.2 Major Manufacturers
2.3 Market Size
3 SURVEY ON SALES STATUS OF SODIUM HYALURONATE IN CHINA, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 SURVEY ON MARKET SHARE OF MAJOR MANUFACTURERS OF SODIUM HYALURONATE IN CHINA, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 SURVEY ON DOSAGE FORMS OF SODIUM HYALURONATE IN CHINA, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume
6 REFERENCE PRICE OF SODIUM HYALURONATE IN CHINESE HOSPITALS IN 2014
6.1 URSAPHARM Arzneimittel GmbH Co.KG (GE) (Trade Name: Hycosan)
6.2 Shanghai Haohai Biological Technology Co., Ltd
6.3 Shanghai Jingfeng Pharmaceutical Co., Ltd (Trade Name: Baibei)
6.4 Santen Pharmaceutical Co., Ltd (Japan) (Trade Name: Hialid)
6.5 Bausch & Lomb (Trade Name: Shipeite)
6.6 United Laboratories (Trade Name: Liangjingjing)
6.7 Seikagaku Corporation (Japan) (Trade Name: Artz)
7 MAJOR MANUFACTURERS OF SODIUM HYALURONATE IN CHINESE MARKET, 2010-2014
7.1 United Laboratories
7.2 Bausch & Lomb
7.3 Shanghai Jingfeng Pharmaceutical Co., Ltd
7.4 Shanghai Haohai Biological Technology Co., Ltd
7.5 Santen Pharmaceutical Co., Ltd (Japan)
8 MARKET OUTLOOK OF SODIUM HYALURONATE IN CHINA, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape
TABLE OF SELECTED CHARTS
Chart Approval Information of Sodium Hyaluronate in China
Chart Sales Status of Sodium Hyaluronate in China
Chart Sales Value of Sodium Hyaluronate in China, 2010-2014
Chart Sales Value of Sodium Hyaluronate in Some Regions in China, 2010-2014
Chart Sales Volume of Sodium Hyaluronate in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Sodium Hyaluronate for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Sodium Hyaluronate Made by Seikagaku (Japan) in China, 2010-2014
Chart Sales Value and Market Share of Sodium Hyaluronate Made by Santen (Japan) in China, 2010-2014
Chart Sales Value and Market Share of Sodium Hyaluronate Made by Bausch & Lomb in China, 2010-2014
Chart Sales Value and Market Share of Sodium Hyaluronate Made by URSAPHARM(GE) in China, 2010-2014
Chart Sales Value and Market Share of Sodium Hyaluronate Made by Shanghai Jingfeng in China, 2010-2014
Chart Sales Value and Market Share of Sodium Hyaluronate Injection in China, 2010-2014
Chart Sales Value and Market Share of Sodium Hyaluronate Eye Drop in China, 2010-2014
Chart Price of Sodium Hyaluronate Made by URSAPHARM Arzneimittel GmbH Co.KG (GE) in Some Chinese Cities in 2014
Chart Price of Sodium Hyaluronate Made by Shanghai Haohai Biological Technology Co., Ltd in Some Chinese Cities in 2014
Chart Price of Sodium Hyaluronate Made by Shanghai Jingfeng Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Sodium Hyaluronate Made by Santen Pharmaceutical Co., Ltd (Japan) in Some Chinese Cities in 2014
Chart Price of Sodium Hyaluronate Made by Bausch & Lomb in Some Chinese Cities in 2014
Chart Price of Sodium Hyaluronate Made by United Laboratories in Some Chinese Cities in 2014
1.1 Indication
1.2 Sales Status in Global Market
2 MARKET PROFILE OF SODIUM HYALURONATE IN CHINA
2.1 Patent and Approval Status of Sodium Hyaluronate in China
2.2 Major Manufacturers
2.3 Market Size
3 SURVEY ON SALES STATUS OF SODIUM HYALURONATE IN CHINA, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 SURVEY ON MARKET SHARE OF MAJOR MANUFACTURERS OF SODIUM HYALURONATE IN CHINA, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 SURVEY ON DOSAGE FORMS OF SODIUM HYALURONATE IN CHINA, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume
6 REFERENCE PRICE OF SODIUM HYALURONATE IN CHINESE HOSPITALS IN 2014
6.1 URSAPHARM Arzneimittel GmbH Co.KG (GE) (Trade Name: Hycosan)
6.2 Shanghai Haohai Biological Technology Co., Ltd
6.3 Shanghai Jingfeng Pharmaceutical Co., Ltd (Trade Name: Baibei)
6.4 Santen Pharmaceutical Co., Ltd (Japan) (Trade Name: Hialid)
6.5 Bausch & Lomb (Trade Name: Shipeite)
6.6 United Laboratories (Trade Name: Liangjingjing)
6.7 Seikagaku Corporation (Japan) (Trade Name: Artz)
7 MAJOR MANUFACTURERS OF SODIUM HYALURONATE IN CHINESE MARKET, 2010-2014
7.1 United Laboratories
7.2 Bausch & Lomb
7.3 Shanghai Jingfeng Pharmaceutical Co., Ltd
7.4 Shanghai Haohai Biological Technology Co., Ltd
7.5 Santen Pharmaceutical Co., Ltd (Japan)
8 MARKET OUTLOOK OF SODIUM HYALURONATE IN CHINA, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape
TABLE OF SELECTED CHARTS
Chart Approval Information of Sodium Hyaluronate in China
Chart Sales Status of Sodium Hyaluronate in China
Chart Sales Value of Sodium Hyaluronate in China, 2010-2014
Chart Sales Value of Sodium Hyaluronate in Some Regions in China, 2010-2014
Chart Sales Volume of Sodium Hyaluronate in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Sodium Hyaluronate for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Sodium Hyaluronate Made by Seikagaku (Japan) in China, 2010-2014
Chart Sales Value and Market Share of Sodium Hyaluronate Made by Santen (Japan) in China, 2010-2014
Chart Sales Value and Market Share of Sodium Hyaluronate Made by Bausch & Lomb in China, 2010-2014
Chart Sales Value and Market Share of Sodium Hyaluronate Made by URSAPHARM(GE) in China, 2010-2014
Chart Sales Value and Market Share of Sodium Hyaluronate Made by Shanghai Jingfeng in China, 2010-2014
Chart Sales Value and Market Share of Sodium Hyaluronate Injection in China, 2010-2014
Chart Sales Value and Market Share of Sodium Hyaluronate Eye Drop in China, 2010-2014
Chart Price of Sodium Hyaluronate Made by URSAPHARM Arzneimittel GmbH Co.KG (GE) in Some Chinese Cities in 2014
Chart Price of Sodium Hyaluronate Made by Shanghai Haohai Biological Technology Co., Ltd in Some Chinese Cities in 2014
Chart Price of Sodium Hyaluronate Made by Shanghai Jingfeng Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Sodium Hyaluronate Made by Santen Pharmaceutical Co., Ltd (Japan) in Some Chinese Cities in 2014
Chart Price of Sodium Hyaluronate Made by Bausch & Lomb in Some Chinese Cities in 2014
Chart Price of Sodium Hyaluronate Made by United Laboratories in Some Chinese Cities in 2014
